Background: Subcortical vascular dementia (SVaD) is one of the most common dementias, after Alzheimer's disease (AD) dementia. Few survival analyses in SVaD patients have been reported. Methods: The dates and causes of death of 146 SVaD and 725 AD patients were included. We used the Cox proportional hazards model to compare survival between SVaD and AD patients and to explore possible factors related to survival of SVaD patients. Results: The median survival time after the onset of SVaD (109 months) was shorter than that recorded for AD (152 months). The most common cause of death in SVaD was stroke (47.1%). Factors associated with shorter survival in SVaD were late onset, male sex, worse baseline cognition, absence of hypertension and a family history of stroke. Conclusions: Stroke prevention may be important in SVaD treatment because 47.1% of SVaD patients died of stroke. A family history of stroke and absence of hypertension were associated with a shorter survival in SVaD, suggesting the existence of genetic or unknown risk factors.

Keywords:
Survival analysis, Stroke, Dementia, Cause of death
1.
Dubois MF, Hébert R: The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology 2001;20:179-187.
2.
Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, Sueishi K, Tsuneyoshi M, Fujishima M: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995;45:1161-1168.
3.
Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC: Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-436.
4.
Ross GW, Petrovitch H, White LR, Masaki KH, Li CY, Curb JD, Yano K, Rodriguez BL, Foley DJ, Blanchette PL, Havlik R: Characterization of risk factors for vascular dementia: The Honolulu-Asia aging study. Neurology 1999;53:337-343.
5.
Wardlaw JM, Smith C, Dichgans M: Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483-497.
6.
Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, Jagust W, Chui H, Mack WJ: Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry 2010;167:589-597.
7.
Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP: The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999;30:1230-1233.
8.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text revision. Washington, American Psychiatric Association, 2000.
9.
Erkinjuntti T: Subcortical vascular dementia. Cerebrovasc Dis 2002;13(suppl 2):58-60.
10.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
11.
The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
12.
Kang SJ, Jeong Y, Lee BH, Baek MJ, Kwon JC, Chin J, Na DL: How early are initial symptoms recognized in Korean patients with Alzheimer's disease? Int J Geriatr Psychiatry 2004;19:699-700.
13.
Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, Folstein M, Stern Y: A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol 1995;52:961-966.
14.
Shinagawa S, Toyota Y, Ishikawa T, Fukuhara R, Hokoishi K, Komori K, Tanimukai S, Ikeda M: Cognitive function and psychiatric symptoms in early- and late-onset frontotemporal dementia. Dement Geriatr Cogn Disord 2008;25:439-444.
15.
Go SM, Lee KS, Seo SW, Chin J, Kang SJ, Moon SY, Na DL, Cheong HK: Survival of Alzheimer's disease patients in Korea. Dement Geriatr Cogn Disord 2013;35:219-228.
16.
Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH: Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74.
17.
Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-1129.
18.
Ay H, Arsava EM, Rosand J, Furie KL, Singhal AB, Schaefer PW, Wu O, Gonzalez RG, Koroshetz WJ, Sorensen AG: Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 2008;39:1409-1413.
19.
Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y: Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002;33:1536-1540.
20.
Arsava EM, Rahman R, Rosand J, Lu J, Smith EE, Rost NS, Singhal AB, Lev MH, Furie KL, Koroshetz WJ, Sorensen AG, Ay H: Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 2009;72:1403-1410.
21.
Kim SH, Seo SW, Go SM, Chin J, Lee BH, Lee JH, Han SH, Na DL: Pyramidal and extrapyramidal scale (PEPS): a new scale for the assessment of motor impairment in vascular cognitive impairment associated with small vessel disease. Clin Neurol Neurosurg 2011;113:181-187.
22.
Nadkarni NK, McIlroy WE, Mawji E, Black SE: Gait and subcortical hyperintensities in mild Alzheimer's disease and aging. Dement Geriatr Cogn Disord 2009;28:295-301.
23.
Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A: A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-158.
24.
Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B: Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998;46:444-452.
25.
Chui HC: Subcortical ischemic vascular dementia. Neurol Clin 2007;25:717-740, vi.
26.
O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123.
27.
Lee JH, Kim SH, Kim GH, Seo SW, Park HK, Oh SJ, Kim JS, Cheong HK, Na DL: Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 2011;77:18-25.
28.
Yoon CW, Shin JS, Kim HJ, Cho H, Noh Y, Kim GH, Chin JH, Oh SJ, Kim JS, Choe YS, Lee KH, Lee JH, Seo SW, Na DL: Cognitive deficits of pure subcortical vascular dementia vs. Alzheimer disease: PiB-PET-based study. Neurology 2013;80:569-573.
29.
Ye BS, Kim GH, Cho H, Kim HJ, Noh Y, Yoon CW, Kim SH, Park HK, Kim ST, Choe YS, Lee KH, Kim JS, Oh SJ, Seo SW, Lee JH, Na DL: Poor prognostic factors in subcortical vascular dementia - a longitudinal cohort study of amyloid PET imaging for subcortical vascular dementia (AMPETIS). Alzheimer's Association International Conference, Boston, July 17, 2013.
30.
Skoog I, Gustafson D: Update on hypertension and Alzheimer's disease. Neurol Res 2006;28:605-611.
31.
Razay G, Williams J, King E, Smith AD, Wilcock G: Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study. Dement Geriatr Cogn Disord 2009;28:70-74.
32.
Vinters HV: Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
33.
Chung SJ, Kim JH, Cho JH, Kim GS, Choi SA, Lee PH, Lee JH: Subcortical vascular dementia (SVaD) without hypertension (HTN) may be a unique subtype of vascular dementia (VaD). Arch Gerontol Geriatr 2014;58:231-235.
34.
Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998;50:208-216.
35.
Vemmos KN, Bots ML, Tsibouris PK, Zis VP, Takis CE, Grobbee DE, Stamatelopoulos S: Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: the Arcadia Stroke Registry. J Neurol Neurosurg Psychiatry 2000;69:595-600.
36.
Appelros P, Nydevik I, Viitanen M: Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003;34:122-126.
37.
Lisabeth LD, Smith MA, Brown DL, Uchino K, Morgenstern LB: Family history and stroke outcome in a bi-ethnic, population-based stroke surveillance study. BMC Neurol 2005;5:20.
38.
Lv W, Lin Y, Song W, Sun K, Yu H, Zhang Y, Zhang C, Li L, Suo M, Hui R, Chen J: Variants of COL3A1 are associated with the risk of stroke recurrence and prognosis in the Chinese population: a prospective study. J Mol Neurosci 2014;53:196-203.
39.
Zhang W, Sun K, Zhen Y, Wang D, Wang Y, Chen J, Xu J, Hu FB, Hui R: VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. Stroke 2009;40:2720-2726.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.